Manuel Paz-Infanzon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Manuel Paz-Infanzon has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Adrián Camacho-Ortiz
Department of Infectious Diseases, Hospital Universitario “Dr. José Eleuterio González,” Monterrey, Nuevo León
2 shared publications - Carl Boodman
Department of Clinical Sciences, Institute of Tropical Medicine , Antwerp
1 shared publication - Carlos Cervera
Department of Medicine University of Alberta Edmonton Canada
1 shared publication - Dima Kabbani
University of Alberta
1 shared publication - Eduardo Perez-Alba
Servicio de Infectología, Hospital Universitario "Dr. José Eleuterio González", Monterrey, Mexico
1 shared publication Efrat Orenbuch-Harroch
Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
1 shared publication
Latest Publications
- 13 June 2026
- Published by Taylor & Francis in Future Microbiology
- Vol. 21 (9) , 889-894
Mycobacterium colombiense isolation among people living with human immunodeficiency virus: a case series
Mycobacterium colombiense is a seldom reported non-tuberculous mycobacteria causing infections mostly in immunosuppressed patients. Thus, we present the findings of three M. colombiense isolation cases from a third-level hospital in Monterrey, Mexico, during 2020-2024. Mycobacterial identification was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and Anyplex™ MTB/NTM Real-time Detection. Patients were people living with Human Immunodeficiency Virus (PLHIV), with pneumonia and lymphadenopathy. Patients had high HIV viral loads and low CD4 counts (21-103 cells/mm3). None of the cases had specific Mycobacterium avium complex (MAC) treatment, and all of them showed clinical improvement. Current non-tuberculous mycobacteria discrimination tests may not effectively diagnose significant pathogens like M. colombiense, potentially leading to delays in treatment and negatively impacting patient outcomes.
- 13 June 2026
- Published by Taylor & Francis in Future Microbiology
- Vol. 21 (9) , 889-894
Mycobacterium colombiense isolation among people living with human immunodeficiency virus: a case series
Mycobacterium colombiense is a seldom reported non-tuberculous mycobacteria causing infections mostly in immunosuppressed patients. Thus, we present the findings of three M. colombiense isolation cases from a third-level hospital in Monterrey, Mexico, during 2020-2024. Mycobacterial identification was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and Anyplex™ MTB/NTM Real-time Detection. Patients were people living with Human Immunodeficiency Virus (PLHIV), with pneumonia and lymphadenopathy. Patients had high HIV viral loads and low CD4 counts (21-103 cells/mm3). None of the cases had specific Mycobacterium avium complex (MAC) treatment, and all of them showed clinical improvement. Current non-tuberculous mycobacteria discrimination tests may not effectively diagnose significant pathogens like M. colombiense, potentially leading to delays in treatment and negatively impacting patient outcomes.
- Open Access
- 24 September 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (2) , 417-423
Donor-derived bartonellosis in solid organ transplant recipients from unhoused donors in Alberta
- 24 September 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (2) , 417-423
Open AccessDonor-derived bartonellosis in solid organ transplant recipients from unhoused donors in Alberta
- Open Access
Vaccine-Associated Rubella Caused by the RA 27/3 Strain
Vaccine-associated rubella is a very rare adverse effect after rubella vaccination; we report the characteristics of a young women who, after a vaccination campaign where she received three different vaccines against influenza, tetanus/diphtheria, and measles/rubella, developed a fever and rash consistent with rubella disease that was confirmed by sequencing of the virus. The evolution was favorable. The woman had two close contacts who did not develop the disease. Follow-up of the patient and her contacts was important to detect complications and for epidemiology surveillance.
Open AccessVaccine-Associated Rubella Caused by the RA 27/3 Strain
Vaccine-associated rubella is a very rare adverse effect after rubella vaccination; we report the characteristics of a young women who, after a vaccination campaign where she received three different vaccines against influenza, tetanus/diphtheria, and measles/rubella, developed a fever and rash consistent with rubella disease that was confirmed by sequencing of the virus. The evolution was favorable. The woman had two close contacts who did not develop the disease. Follow-up of the patient and her contacts was important to detect complications and for epidemiology surveillance.